BeiGene's $933m IPO covered as biotech in hot demand
BeiGene had covered books for its HK$7.3bn ($933m) IPO in Hong Kong by Tuesday morning, just two days after the deal hit screens.
Unlock this article.
The content you are trying to view is exclusive to our subscribers.
To unlock this article: